As of early May 2026, MediWatch is tracking 222 active medicine shortages across the UK. This monthly update summarises the key changes, the medications most affected, and what patients should do.
Key Shortages This Month
Ramipril — SSP Extended
The Serious Shortage Protocol for Ramipril 1.25mg capsules and 2.5mg tablets remains active. Pharmacists can continue to supply alternative strengths and quantities without a new prescription. If you take ramipril, speak to your pharmacist before your supply runs low.
Propranolol MR Capsules
Supply of propranolol 80mg and 160mg modified-release capsules remains constrained. The DHSC Medicine Supply Notification is ongoing. Immediate-release propranolol tablets are generally available as an alternative for many patients — discuss with your GP before switching formulations.
Creon (Pancreatic Enzymes)
Both Creon 10000 and 25000 capsules remain under active Serious Shortage Protocols. These are critical for patients with cystic fibrosis, chronic pancreatitis, and pancreatic cancer. Pharmacists can supply reduced quantities under SSP — no prescription charge applies for SSP-supplied Creon.
HRT — Estradiol Products
Multiple estradiol products remain under SSP, including Lenzetto spray, Oestrogel, and Sandrena gel sachets. Progynova TS patches are subject to a medium-tier MSN. Pharmacists can substitute equivalent products under SSP authority. If your specific HRT product is unavailable, ask your pharmacist about equivalent alternatives.
Fluoxetine
Several fluoxetine strengths — including 10mg capsules, 10mg tablets, 30mg capsules and 40mg capsules — are under active SSPs. Check the fluoxetine page for current status. Most other SSRIs (sertraline, citalopram, escitalopram) remain well-supplied.
ADHD Medications
Elvanse (lisdexamfetamine) supply has improved compared to 2024 but remains intermittent across strengths. Patients should allow at least 2 weeks' lead time for reorders. Methylphenidate extended-release and atomoxetine have more consistent supply.
Insulin & GLP-1
Multiple insulin products continue to face supply pressure, including Fiasp, Humalog vials, and Levemir. The global GLP-1 shortage (Ozempic, Wegovy, Mounjaro) continues with demand outpacing manufacturing capacity. NHS England maintains strict prescribing restrictions for weight-management GLP-1 use.
What to Do If Your Medication Is Short
- Don't wait until you're out. Order repeat prescriptions as early as your GP surgery allows — ideally 2 weeks before you need them.
- Try multiple pharmacies. Shortages are often regional. A pharmacy a few miles away may have stock when your local one doesn't.
- Ask about alternatives. For many shortages, pharmacists can supply an equivalent medicine under a Serious Shortage Protocol without you needing a new prescription.
- Sign up for alerts. Get free MediWatch alerts for your specific medications and be notified the moment supply status changes.
Get Alerts for Your Medications
MediWatch tracks 222 active shortages across 896 medications. Sign up free and get notified when your prescription is affected.
Start Monitoring FreeSources: DHSC Medicine Supply Notifications, NHSBSA Serious Shortage Protocols, Community Pharmacy England. Data accurate as of 12 May 2026.